Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001571049-15-008692
Filing Date
2015-11-02
Accepted
2015-11-02 17:00:59
Documents
1
Group Members
JACK C. BENDHEIM

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D t1502520_sc13da.htm SC 13D/A 59684
  Complete submission text file 0001571049-15-008692.txt   61382
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-88114 | Film No.: 151191306
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666
Business Address 300 FRANK W. BURR BLVD., STE 21 TEANECK NJ 07666 2013297300
BFI Co., LLC (Filed by) CIK: 0001601607 (see all company filings)

EIN.: 262105186 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A